2250
M. Furukawa et al. / Phytochemistry 72 (2011) 2244–2252
Table 5
30 °C. The combine ethanol extract was concentrated under re-
Inhibitory Effects of Isolated Compounds on Release of LTC4.
duced pressure to give an oily material (81.6 g) which was applied
to a Diaion HP-20 resin column, and then eluted successively with
MeOH–H2O (4:6, Fr. A), (7:3, Fr. B), MeOH (Fr. C) and acetone (Fr.
D). Each fraction was concentrated in vacuo to give Fr.A (22.5 g),
Fr.B (5.4 g), Fr.C (28.9 g), and Fr.D (18.9 g). Only Fr.B and Fr.C
showed inhibitory activity on secretion of LTC4 at a concentration
Compounds
IC50 (
l
M)
Compounds
IC50 (lM)
1
2
3
4
5
6
7
8
42.9
12
13
14
15
16
17
18
19
>100
>100
92.5
13.6
>100
>100
>100
>100
>100
>100
>100
39.9
a
-
of 100 lg/ml, in the bio-assay guided fractionation Fr. C was tritu-
39.9
76.0
rated with MeOH and the insoluble material was collected and
recrystallized from EtOAc to give 19 (6100 mg). The mother liquor
was concentrated to leave an oily material which was subjected to
silica gel CC, this being eluted successively with hexane–EtOAc
(5:1, 3.6 l, Fr. C-1–C-3), (3:1, 2.0 l, Fr.C-4), (2:1, 1.0 l, Fr.C-5), (1:1,
2.4 l, Fr.C-6), EtOAc (2.0 l, Fr.C-7) and MeOH (2.0 l, Fr.C-8) to give
eight fractions. Fr. C-3 was fractionated by reversed phase HPLC
{Kaseisorb LC PH SUPER, 20 ꢁ 250 mm (column A), MeOH–H2O
(75:25), flow rate 8 ml minꢀ1} to afford four fractions (Fr.C-3–1-
C-3–4). Fr.C-3–3 was purified by reversed phase HPLC {Kaseisorb
LC ODS PH SUPER, 10 ꢁ 250 mm (column B), MeOH–H2O (9:1),
flow rate 3 ml minꢀ1} to yield 16 (38 mg). Fr.C-4 was fractionated
by reversed phase HPLC {column A, MeOH-H2O (8:2), flow rate
8 ml minꢀ1} to afford four fractions (Fr. C-4–1–C-4–4). Fr.C-4–1
was further separated by reversed phase HPLC {column B,
MeOH–H2O (85:15), flow rate 3 ml minꢀ1} to give 1 (12 mg) and
10 (12 mg). Purification of Fr.C-4–2 using reversed phase HPLC
{column B, MeOH–H2O (85:15), flow rate 3 ml minꢀ1} to give 9
(75 mg). Separation of Fr. C-5 by reversed phase HPLC {column A,
MeOH–H2O (8:2), flow rate 8 ml minꢀ1} gave fourteen fractions
(Fr.C-5–1–C-5–14). Purification of Fr. C-5–3 by reversed phase
b
-
b
9
10
11
20
21
Ketotifen
-
b
23.3
>100
-
46.8
a
not done.
b
Compounds (19, 20 and 21) exhibit cytotoxicity at the concentration of >10 lM.
compounds (1, 9, 10 and 15) having 1,4- or 1,2-dihydroxybenzene
moieties and flavones (17 and 18) exhibit potent inhibition of re-
lease of LTC4.
2.3. Conclusions
The constituents of H. cuspidatus have been investigated by sev-
eral Chinese research groups (Ablizl et al., 2009; Xue et al., 1990).
However, those studies have mainly focused on the essential oil of
this plant. In the present studies, two monoterpenoids (3 and 4), a
sesquiterpenoid (2), a diterpenoid (1) and four phenethyl gluco-
sides (5–8), together with fourteen known compounds, were iso-
lated from the whole herb of H. cuspidatus. The effect of the
isolated compounds on the secretion of LTC4 from primary alveolar
cells of Wistar ratss is also investigated. The phenolic compounds
(1, 9, 10 and 15) having 1,4- or 1,2-dihydroxybenzene moieties
and flavones (17 and 18) potently inhibited release of LTC4 from
primary alveolar cells of Wistar rats.
HPLC {column B, MeOH–H2O (75:25), flow rate 3 ml minꢀ1
}
yielded 2 (15 mg). Fr. C-5–4 was purified by reversed phase HPLC
{column B, MeOH–H2O (75:25), flow rate 3 ml minꢀ1} to give 18
(4 mg). Compound 17 (7 mg) was obtained from Fr.C-5–6 by puri-
fication using reversed phase HPLC {column B (MeOH–H2O (8:2),
flow rate 3 ml minꢀ1}. Fr.C-5–10 was purified by reversed phase
HPLC {Senshu Pak PEGASIL ODS, 10
u
ꢁ 250 mm (column C),
MeOH–H2O (9:1), flow rate 3 ml minꢀ1} to give 22 (16 mg). Com-
pounds 20 (47 mg) and 21 (29 mg) were obtained from Fr. C-5–
12 and Fr. C-5–11, respectively, by purification using reversed
phase HPLC {column C, MeOH-H2O (9:1), flow rate 3 ml minꢀ1}.
Fr. B (5.4 g) was subjected to silica gel CC, this being eluted, succes-
sively with CHCl3–MeOH–H2O {100:1:0 (300 ml, Fr. B-1), 10:1:0.05
(1650 ml, Fr. B-2), 8:2:0.2 (2500 ml, Fr. B-3), 7:3:0.3 (1000 ml, Fr.
B-4, B-5), 6:4:0.5 (1000 ml, Fr. B-6), 6:4:1 (2000 ml, Fr. B-7) and
acetone (Fr. B-8)} to give eight fractions. Fr.B-1 was further frac-
tionated by silica gel CC {toluene–acetone 20:1 (500 ml, Fr.B-1–
1), 10:1 (550 ml, Fr.B-1–2), 5:1 (1020 ml, Fr.B-1–3), 3:1 (600 ml,
Fr.B-1–4), 2:1 (600 ml), 1:1 (600 ml), acetone (800 ml) Fr.B-1–5,
MeOH (1000 ml, Fr.B-1–6)} to yield six fractions. Separation of
Fr.B-1–4 by reversed phase HPLC {column A, MeOH–H2O (4:6),
flow rate 3 ml minꢀ1} afforded twelve fractions (Fr.B-1–4-1-B-1–
4-12). Concentration of Fr.B-1–4-5 gave 3 (37 mg). Further separa-
tion of Fr.B-1–4-6 by reversed phase HPLC {column B, CH3CN–H2O
(3:7), flow rate 3 ml minꢀ1} gave 13 (7 mg). Fr.B-1–4-7 was further
purified by reversed phase HPLC (column B, CH3CN–H2O (32:68),
flow rate 3 ml minꢀ1) to give 11 (5 mg). Compound 12 (17 mg)
was obtained from Fr. B-1–4-8 by purification using reversed phase
HPLC {column B, CH3CN–H2O (3:7), flow rate 3 ml minꢀ1}. Separa-
tion of Fr.B-1–4-9 by reversed phase HPLC {column B, CH3CN–H2O
(25:75), flow rate 3 ml minꢀ1} yielded 14 (9 mg). Fr.B-1–4-11 was
further purified by reversed phase HPLC {column B, CH3CN–H2O
(3:7), flow rate 3 ml minꢀ1} to give 4 (6 mg). Fr.B-3 was fraction-
3. Experimental
3.1. General
1H and 13C NMR spectra were measured on a JEOL JNM lambda-
400, 500 spectrometer or JEOL ECA-600 in CDCl3 or MeOH-d4
containing TMS as an internal standard, with MS spectra being
recorded on a HITACHI M-2000 instrument. IR spectra were
acquired on a JASCO IR A-2. Column chromatography (cc) was car-
ried out on silica gel (Wakogel C-200) and Diaion HP-20 (Nippon
Rensui). HPLC was conducted with a Spectra Physics SP 8800 and
Sensyu SSC-3160 pump equipped with either ERC-7520 (ERMA)-
RI or HITACHI L-400-UV detector. Silica gel 60 F254 (Merck) pre-
coated TLC plates were used and the detection was carried out
by spraying 5% H2SO4 solution followed by heating.
3.2. Plant material
H. cuspidatus was collected in Xinjiang province, China and
identified by Mr. Shen Jin Gui, Institute of Materia Medica, Shang-
hai Institutes for Biological Sciences, Chinese Academy of Sciences.
A voucher specimen has been deposited in the above Institute and
the Laboratory of Medicinal Chemistry, College of Pharmacy, Nihon
University. (voucher No. HC-001, Laboratory of Medicinal
Chemistry).
3.3. Extraction and isolation
ated by reversed phase HPLC {CAPCELL PAK UG, 20
u
ꢁ 250 mm
(column D), MeOH–H2O (45:55), flow rate 8 ml minꢀ1} to afford
four fractions (Fr.B-3–1–B-3–4). Separation of Fr.B-3–2 by reversed
Dried whole herb of H. cuspidatus (1.5 kg) was extracted with
EtOH of (6.0 l ꢁ 4) under ultrasonication for each 30 min at 20–
phase HPLC {column A, CH3CN–H2O (15:85), flow rate 3 ml minꢀ1
}